IL Therapeutics

IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP (“Western Life Sciences”) and in 2006 its shares were purchased by Pacgen Biopharmaceuticals Corporation (“Pacgen”)^[1]

Additional recommended knowledge

Don't let static charges disrupt your weighing accuracy

Recognize and detect the effects of electrostatic charges on your balance

Daily Sensitivity Test

History

Saskatchewan Research Council operates a bio-processing laboratory which facilitated biomedical research. IL Therapeutics was developed from research first begun at the Western College of Veterinary Medicine

Pharmaceuticals

Currently IL Therapeutics is working on a drug candidate, IL-8(3-73)K11R/G31P (“PAC-G31P”) for relief of Acute Respiratory Distress Syndrome (ARDS)^[2] The Saskatchewan Research council, SRC also assisted with the funding of this project through the Agriculture Development Fund - SRC Industry Venture Fund.^[3]The successful progression of G31PRecently the University of Saskatchewan Industry Liaison Office (ILO) decided to commercialize a commercialize this new drug treatment.^[4] This research has been sponsored by a $3 million boost from the Western Life Sciences Venture Fund (WLS)^[4]

References

See also

• Biotechnology
• List of biotechnology companies
• Innovation Place Research Park
• University of Saskatchewan